European Pharmaceutical Review
MAY 4, 2023
Amivantamab was the first bispecific monoclonal antibody (BsMAb) approved in the EU to treat advanced NSCLC with EGFR exon 20 insertion mutations post chemotherapy. Global Bispecific Antibodies for Cancer Market 2023-2027. Personalized medicine at FDA. Internet] Personalized Medicine Coalition. cited 2023Apr. Available from: [link] 8.
The Happy PharmD
SEPTEMBER 4, 2024
Did you know that the infusion pharmacy market is projected to reach $20 billion dollars by 2027? From chemotherapy to nutrition support and infectious disease treatments, infusion pharmacists play a vital role in delivering specialized care directly to patients. Many pharmacists wonder how this growth could impact their careers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
OCTOBER 4, 2023
One area of interest is in oncology , where bispecific antibodies can be used to target two different antigens at the same time, leading to improved efficacy and reduced toxicity compared to traditional chemotherapy. during the period 2023-2035. during the period 2023-2035. during the period 2023-2035.
Blog: Ask a Student Pharmacist
JUNE 21, 2023
Particularly, we devote a large portion of our research to identifying novel compounds that impact cellular uptake or inhibit drug efflux - the most common mechanism underlying acquired drug resistance in cancer, pinpointing the transporters or targets involved in these processes, and evaluating regimens to produce desirable anti-cancer responses.
The FDA Law Blog
FEBRUARY 11, 2024
The regulated cannabis marketplace brings in billions of dollars in revenue into state and federal governments, with predictions that cannabis sales will exceed $53 billion by 2027. Studies have found that marijuana access has public health benefits by reducing the rates of opioid use and opioid deaths.
Expert insights. Personalized for you.
98 
Let's personalize your content